Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A well differentiated, low or intermediate grade tumor with neuroendocrine differentiation that arises from the jejunum.
Biomarker and diagnostic research for jejunal neuroendocrine tumor, well differentiated, low or intermediate grade has been reported in the published literature.
No clinical trials have been registered for jejunal neuroendocrine tumor, well differentiated, low or intermediate grade.
231 publications have been identified in PubMed for jejunal neuroendocrine tumor, well differentiated, low or intermediate grade. Kisho has analyzed 165 by research type. Research spans Clinical Trial Publication (35%), Review / Meta-Analysis (21%), and Basic Science / Preclinical (16%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results | 57 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 3:12 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries | 35 | 21% |
Laboratory research | 27 | 16% |
Testing and diagnosis research | 25 | 15% |
Disease patterns and progression | 17 | 10% |
Patient case studies | 3 | 2% |
New treatment approaches | 1 | 1% |
Virata MC (2026). [PMID: 41903203](https://pubmed.ncbi.nlm.nih.gov/41903203/). *Neuro Oncol*. [Basic Science / Preclinical]
Hou G (2026). [PMID: 41134321](https://pubmed.ncbi.nlm.nih.gov/41134321/). *Eur J Nucl Med Mol Imaging*. [Diagnostic / Biomarker]
Sountoulidis A (2026). [PMID: 41851103](https://pubmed.ncbi.nlm.nih.gov/41851103/). *Nat Commun*. [Basic Science / Preclinical]
Patek GC (2026). [PMID: 29083604](https://pubmed.ncbi.nlm.nih.gov/29083604/). *Unknown Journal*. [Diagnostic / Biomarker]
Hercent A (2026). [PMID: 41416936](https://pubmed.ncbi.nlm.nih.gov/41416936/). *The Journal of pathology*. [Basic Science / Preclinical]
Scuderi S (2026). [PMID: 41002165](https://pubmed.ncbi.nlm.nih.gov/41002165/). *J Natl Cancer Inst*. [Diagnostic / Biomarker]
van den Heerik ASVM (2026). [PMID: 41449145](https://pubmed.ncbi.nlm.nih.gov/41449145/). *The Lancet. Oncology*. [Review / Meta-Analysis]
Lu S (2026). [PMID: 42159372](https://pubmed.ncbi.nlm.nih.gov/42159372/). *BJU Int*. [Clinical Trial Publication]
Živić K (2026). [PMID: 41677640](https://pubmed.ncbi.nlm.nih.gov/41677640/). *Cells*. [Basic Science / Preclinical]
Sheng YH (2026). [PMID: 41693974](https://pubmed.ncbi.nlm.nih.gov/41693974/). *World journal of gastroenterology*. [Clinical Trial Publication]